Novocure Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +272.5% | -16.5% | -62.8% | -338.2% | – | – | |
| – | +60.7% | +79.3% | +35.8% | +17.3% | -6.1% | +8.2% | +12.0% | +3.6% | +3.2% | -231.4% | – | |
| – | +156.5% | +86.7% | +22.5% | +46.9% | +31.5% | +44.5% | +25.3% | +12.7% | +8.1% | +38.4% | -34.5% | |
| – | +157.3% | +129.9% | -3.2% | +51.9% | +28.9% | +45.4% | +34.9% | +2.8% | – | – | – | |
| – | – | – | – | – | -313.2% | – | – | -59.4% | +150.6% | -114.5% | – | |
| – | +342.9% | +72.0% | -58.3% | -8.9% | +56.2% | +42.8% | +61.5% | -11.6% | +26.9% | +58.2% | -37.8% | |
| – | +149.7% | – | -47.2% | -181.1% | +840.6% | +815.2% | -69.4% | -3.4% | – | -176.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.2% | – | +224.7% | +288.6% | +204.0% | -48.5% | -19.1% | -39.7% | – | – | – | |
| – | – | +219.1% | -100.1% | – | -100.1% | – | -100.0% | +7.7% | -64.3% | – | -648.7% | |
| – | +12,813.2% | -72.9% | -93.1% | +1,242.3% | -11.1% | +613.7% | -94.2% | -39.7% | +1.9% | +472.1% | -599.7% | |
| – | – | -131.8% | – | – | -40.9% | +82.1% | -154.8% | – | – | -160.3% | – | |
| – | – | – | – | – | – | +421.7% | -30.4% | -83.9% | -1,165.0% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.